<SEC-DOCUMENT>0001606498-25-000085.txt : 20250430
<SEC-HEADER>0001606498-25-000085.hdr.sgml : 20250430
<ACCEPTANCE-DATETIME>20250430094743
ACCESSION NUMBER:		0001606498-25-000085
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20250428
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250430
DATE AS OF CHANGE:		20250430

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AVANOS MEDICAL, INC.
		CENTRAL INDEX KEY:			0001606498
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				464987888
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36440
		FILM NUMBER:		25891529

	BUSINESS ADDRESS:	
		STREET 1:		5405 WINDWARD PARKWAY
		STREET 2:		SUITE 100 SOUTH
		CITY:			ALPHARETTA
		STATE:			GA
		ZIP:			30004
		BUSINESS PHONE:		844-428-2667

	MAIL ADDRESS:	
		STREET 1:		5405 WINDWARD PARKWAY
		STREET 2:		SUITE 100 SOUTH
		CITY:			ALPHARETTA
		STATE:			GA
		ZIP:			30004

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Avanos Medical, Inc.
		DATE OF NAME CHANGE:	20180702

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Halyard Health, Inc.
		DATE OF NAME CHANGE:	20140424
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>avns-20250428.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:e3e68b24-25c3-42c3-996b-ac20c52bbb64,g:48bf99d9-a070-4f97-943f-5a2790fc18d0,d:d4d037885ea94af7919be50b04be1a26-->
<html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>avns-20250428</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-22">0001606498</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-23">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-24">April 28, 2025</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="avns-20250428.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001606498</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-28</xbrli:startDate><xbrli:endDate>2025-04-28</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="id4d037885ea94af7919be50b04be1a26_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.035%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.035%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">April 28, 2025</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.035%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;text-align:center"><img src="avns-20250428_g1.jpg" alt="avanoslogo.jpg" style="height:34px;margin-bottom:5pt;vertical-align:text-bottom;width:213px"/></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">AVANOS MEDICAL, INC.</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.035%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.454%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.593%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.681%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.697%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.739%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.604%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-36440</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">46-4987888</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">5405 Windward Parkway</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-8">Suite 100 South</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-9">Alpharetta,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-10">Georgia</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-11">30004</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Zip code)</span></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-12">844</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-13">428-2667</ix:nonNumeric></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:2.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.947%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-17">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.158%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-18">Common Stock - $0.01 Par Value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-19">AVNS</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-20">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-21">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt"><span><br/></span></div><div id="id4d037885ea94af7919be50b04be1a26_7"></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.02&#160;&#160;&#160;&#160;Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 28, 2025, Avanos Medical, Inc. (the &#8220;Company&#8221;) and Michael C. Greiner entered into a Separation and Consulting Agreement (the &#8220;Separation and Consulting Agreement&#8221;). The Separation and Consulting Agreement reflects the terms and conditions relating to Mr. Greiner&#8217;s departure from the Company, as described in the Company&#8217;s Current Report on Form 8-K filed on April 18, 2025. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Separation and Consulting Agreement, the Company will: (i) pay to Mr. Greiner cash severance in the amount of $2,100,000 pursuant to the Company&#8217;s Severance Pay Plan, as amended and restated; (ii) pay to Mr. Greiner his prorated bonus for 2025, which will be determined based on the Company&#8217;s actual performance against the relevant performance goals and paid in 2026 at the same time the Company pays annual bonuses to its senior executives; and (iii) pay 100% of Mr. Greiner&#8217;s monthly COBRA premiums for a period of six months. In addition, the 44,189 time-based restricted stock units (&#8220;TRSUs&#8221;) granted to Mr. Greiner on October 29, 2024 and the 10,000 TRSUs granted to Mr. Greiner on December 3, 2024 will vest immediately. Under the Separation and Consulting Agreement, the Company also engaged Mr. Greiner as an independent contractor through May 16, 2025 to render such professional consulting services as the Company may reasonably request. In consideration of Mr. Greiner&#8217;s performance of such consulting services, the Company will pay Mr. Greiner $50,000. In connection with the Separation and Consulting Agreement, on April 28, 2025 the Company and Mr. Greiner also executed a Full and Final Release of Claims and Covenant Not to Sue (the &#8220;Release&#8221;). The Release provides a full and final general release of claims against the Company for Mr. Greiner&#8217;s period of employment with the Company. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above-described payments and benefits are conditioned upon: (i) Mr. Greiner&#8217;s non-revocation of the Release; (ii) Mr. Greiner&#8217;s execution and non-revocation of a supplemental release of claims against the Company for his consulting period; and (iii) Mr. Greiner&#8217;s continued compliance with the terms of his Confidentiality, Non-Solicitation and Assignment of Business Ideas Agreement with the Company. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing description of the Separation and Consulting Agreement and the Release does not purport to be complete and is qualified in its entirety by reference to the full text of such agreements, which are filed as Exhibit 10.1 and Exhibit 10.2, respectively, to this Current Report on Form 8-K.</span></div><div style="margin-top:6pt"><span><br/></span></div><div id="id4d037885ea94af7919be50b04be1a26_10"></div><div style="-sec-extract:summary;margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01&#160;&#160;&#160;&#160;Financial Statements and Exhibits</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Exhibits.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following exhibits are filed with this Current Report on Form 8-K:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:89.223%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="avnsform8k_04282025xex101.htm">10.1*</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="avnsform8k_04282025xex101.htm">Separation and Consulting Agreement dated April 28, 2025 by and between Avanos Medical, Inc. and Michael C. Greiner</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="avnsform8k_04282025xex102.htm">10.2*</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="avnsform8k_04282025xex102.htm">Full and Final Release of Claims and Covenant Not to Sue dated April 28, 2025 by and between Avanos Medical, Inc. and Michael C. Greiner</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the inline XBRL document)</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> *  Management contracts, compensatory plans or arrangements</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt"><span><br/></span></div><div id="id4d037885ea94af7919be50b04be1a26_13"></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">SIGNATURE</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:4.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.814%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.005%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.814%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AVANOS MEDICAL, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">April 30, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Mojirade James</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mojirade James<br/>Senior Vice President and General Counsel</span></td></tr></table></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>avnsform8k_04282025xex101.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i5174b4401b534ef8aca9ba90d6e9392e_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 10.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SEPARATION AND CONSULTING AGREEMENT</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This SEPARATION AND CONSULTING AGREEMENT (this &#8220;Agreement&#8221;) is made and entered into as of April 28, 2025 by and between Avanos Medical, Inc. (together with its subsidiaries, the &#8220;Company&#8221;) and Michael C. Greiner (&#8220;Employee&#8221;). The Company and Employee are collectively referred to herein as the &#8220;Parties.&#8221;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">RECITALS&#58;</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, Employee is currently employed by the Company&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Company and Employee have agreed that Employee&#8217;s employment with the Company ended on April 18, 2025 (the &#8220;Separation Date&#8221;), following which Employee shall be engaged as a consultant of the Company until May 16, 2025 (the &#8220;Consulting Termination Date&#8221;)&#59; and</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Company and Employee desire to set forth the Parties&#8217; respective rights and obligations with respect to the termination of Employee&#8217;s employment and subsequent service as a consultant with the Company&#59;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of the representations, warranties, covenants and agreements set forth herein, and for the good and valuable consideration set forth herein, the adequacy of which is hereby specifically acknowledged, the Parties, intending to be legally bound, hereby agree as follows&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%;text-decoration:underline">Separation from Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">.  Employee&#8217;s separation from employment is effective as of the Separation Date. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%;text-decoration:underline">Payment Following Separation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">.  To the extent not already paid to Employee, within thirty (30) days of the Separation Date, the Company shall pay to Employee (i) all accrued but unpaid base salary through the Separation Date, (ii) any unused vacation due to Employee as of the Separation Date according to the Company&#8217;s vacation policy currently in effect and as required by law, and (iii) reimbursement for any unreimbursed business expenses properly incurred by Employee in accordance with Company policy prior to the Separation Date (collectively, the &#8220;Accrued Benefits&#8221;).  Employee shall be entitled to all vested benefits under the Company&#8217;s 401(k) Plan and Non-Qualified 401(k) Plan. Employee will receive by separate letter information regarding his rights regarding continuation of health insurance under Section 4980B of the Internal Revenue Code (&#8220;COBRA&#8221;), and to the extent that Employee has such rights, nothing in this Agreement will change or impair those rights.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%;text-decoration:underline">Acknowledgement of Payment of Wages</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">.  By signing below, Employee agrees and acknowledges that he has been paid all outstanding wages through and including the date of his most recent paycheck, less customary and applicable payroll deductions.  Employee further confirms and agrees that he has received all wages, commissions, reimbursements, payments, or other benefits to which he is entitled as a result of his employment with the Company, other than those that have not yet become due pursuant to the Company&#8217;s normal payroll schedule.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Page 1 of 6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 10.1</font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%;text-decoration:underline">Separation Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">(a)&#160;&#160;&#160;&#160;In consideration of Employee&#8217;s promises contained in this Agreement (including, without limitation, the release of claims and covenant not to sue contained in the Release Agreement and the Supplemental Release), and subject to the terms and conditions of this Agreement, the Company hereby agrees to&#58; (i) pay to Employee a prorated portion of his 2025 annual bonus, which shall be determined based upon the Company&#8217;s actual performance against applicable goals established by the Compensation Committee of the Board of Directors of the Company, prorated based on the number of days from the start of the year through the Separation Date, and paid to Employee in 2026 at the same time that the Company pays 2025 annual bonuses to its senior executives&#59; (ii) pay Employee cash severance in the amount of $2,100,000, less applicable withholdings, pursuant to the Company&#8217;s Severance Pay Plan, as amended and restated (the &#8220;Severance Pay Plan&#8221;), and subject to the terms and conditions of the Severance Pay Plan, which cash severance amount will be paid in a lump sum within sixty (60) days following the Separation Date&#59; (iii) pay one hundred percent (100%) of Employee&#8217;s monthly COBRA premiums for a period of six (6) months following the Separation Date&#59; (iv) provide Employee with the consulting engagement described in Section 7 below&#59; and (v) pay to Employee the Consulting Fees described in Section 10(a). In addition, the 44,189 time-based restricted stock units (&#8220;TRSUs&#8221;) granted to Employee on October 29, 2024, and the 10,000 TRSUs granted to Employee on December 3, 2024 will vest immediately upon the Separation Date in accordance with their terms. All other unvested equity awards held by Employee as of the Separation Date will terminate immediately.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">(b)&#160;&#160;&#160;&#160;The payments and benefits described in Section 4(a) are collectively referred to herein as the &#8220;Separation Benefits.&#8221; Except for the Accrued Benefits and the Separation Benefits, to the extent earned by Employee, no compensation or other amounts or benefits will be payable by the Company to Employee in connection with the termination of his employment by the Company. The Parties acknowledge and agree that the Separation Benefits exceed any and all actions, pay, and benefits that the Company might otherwise have owed to Employee by contract or law, and that such payments and benefits constitute good, valuable, and sufficient consideration for Employee&#8217;s release and agreements herein. The Company&#8217;s provision of the Separation Benefits, to the extent earned by Employee, will discharge all obligations of the Company to Employee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:109%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">in connection with his employment by the Company and in connection with the claims released by Employee pursuant to the Release Agreement (as that term is defined below).</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">(c)&#160;&#160;&#160;&#160;Whether or not Employee executes the Release Agreement, Employee will be paid the Accrued Benefits.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">(d)&#160;&#160;&#160;&#160;This Agreement shall be interpreted and administered in a manner so that any amount or benefit payable hereunder shall be paid or provided in a manner that is either exempt from or compliant with the requirements Section 409A of the Internal Revenue Code of 1986, as amended, and applicable Internal Revenue Service guidance and Treasury Regulations issued thereunder (the &#8220;Code&#8221;). Nevertheless, the tax treatment of the Accrued Benefits, the Separation Benefits, or the Consulting Fees (as defined below) to the extent earned by Employee, is not warranted or guaranteed. Neither the Company nor its directors, officers, employees or advisers (other than Employee) shall be held liable for any taxes, interest, penalties or other monetary amounts owed by the Employee as a result of the application of Section 409A of the Code. Regardless of any action the Company takes with respect to any or all taxes, the ultimate </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Page 2 of 6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 10.1</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">liability for all taxes payable with respect to this Agreement shall remain Employee&#8217;s responsibility and may exceed the amount actually withheld by the Company.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%;text-decoration:underline">Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">.  Payment of the Separation Benefits (other than the Consulting Fees) will be subject to reduction to satisfy&#58; (i) all federal, state and local employment and withholding tax obligations to the extent required by law and (ii) any other payroll reductions deemed appropriate by the Company. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%;text-decoration:underline">Eligibility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">.  To be eligible for the Separation Benefits&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">(a)&#160;&#160;&#160;&#160;With respect to the Consulting Fees only, Employee must perform the Consulting Services following the Separation Date and through the Consulting Termination Date as set forth herein. </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">(b)&#160;&#160;&#160;&#160;Employee must execute a Full and Final Release of Claims and Covenant Not to Sue (the &#8220;Release Agreement&#8221;), in the form attached hereto as Exhibit A, within the period specified therein and must not revoke such Release Agreement in writing within the seven (7)-day period following the date on which it is executed. </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">(c)&#160;&#160;&#160;&#160;Employee must execute a Supplemental Release, in the form attached hereto as Exhibit B, on (but not before) the Consulting Termination Date or within seven (7) days after the Consulting Termination Date, and must not revoke such Supplemental Release in writing within the seven (7)-day period following the date on which it is executed.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">(d)&#160;&#160;&#160;&#160;Employee must fully honor his obligations under the Confidentiality, Non-Solicitation and Assignment of Business Ideas Agreement between Employee and the Company, dated on or about January 1, 2020 (the &#8220;Confidentiality Agreement&#8221;).</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">The Company&#8217;s obligation to make the payments and provide the benefits constituting the Separation Benefits shall cease upon Employee&#8217;s material breach of any of these eligibility requirements or any other of his continuing contractual obligations to the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%;text-decoration:underline">Engagement as an Independent Contractor&#59; Consulting Services</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">.  The Company hereby engages Employee as an independent contractor effective as of the Separation Date, and Employee hereby accepts such engagement as an independent contractor, upon the terms and conditions set forth in this Agreement. Employee shall manage, perform, and provide such professional consulting services and advice (the &#8220;Consulting Services&#8221;) as the Company may reasonably request from time to time during the Consulting Period (as defined below)&#59; provided that the Company&#8217;s request shall not interfere with Employee&#8217;s pursuit or acceptance of other employment or services (including self-employment). During the Consulting Period, Employee shall&#58; (a) perform the Consulting Services in a professional, ethical, and competent manner&#59; (b) take no actions that Employee in good faith believes will in any way damage the business or public image or reputation of the Company or its affiliates&#59; (c) abide by the Company&#8217;s and then-current policies or guidelines in all material respects while at the Company&#8217;s facilities or performing the Consulting Services&#59; and (d) not engage in any actions that would create a conflict of interest with the interests of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">8.&#160;&#160;&#160;&#160; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%;text-decoration:underline">Independent Contractor Relationship</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">.  The Parties acknowledge and intend that the relationship of Employee to the Company under this Agreement shall be that of an </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Page 3 of 6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 10.1</font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">independent contractor.  In performing the Consulting Services under this Agreement, Employee shall undertake the Consulting Services according to Employee&#8217;s own means and methods of work, which shall be in the exclusive charge and control of Employee, and which shall not be subject to the control or supervision of the Company, except as to the objectives of those Consulting Services. Employee shall determine Employee&#8217;s own working hours and schedule and shall not be subject to the Company&#8217;s personnel policies and procedures as to hours and schedule.  Employee shall be entirely and solely responsible for Employee&#8217;s actions or inactions and the actions or inactions of any agents, employees or subcontractors, if any, while performing Consulting Services hereunder.  Employee shall not, in any form or fashion, maintain, hold out, represent, state or imply to any other individual or entity that an employer&#47;employee relationship exists between the Company and Employee.  Employee is not granted, nor shall Employee represent that he is or has been granted, any right or authority to make any representation or warranty or assume or create any obligation or responsibility, express or implied, for, on behalf or in the name of the Company, to incur debts for the Company, or to bind the Company in any manner whatsoever.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%;text-decoration:underline">Term of the Agreement and Engagement&#59; Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">.  The term of Employee&#8217;s engagement with the Company as independent contractor under this Agreement shall begin on the Separation Date and continue until May 16, 2025 (the &#8220;Consulting Period&#8221;).  Following the end of the Consulting Period, Employee&#8217;s engagement with the Company under this Agreement shall automatically terminate.  Employee&#8217;s engagement hereunder shall terminate automatically upon Employee&#8217;s death during the Consulting Period, in which case, the Company shall pay any earned but unpaid Consulting Fee (as defined below) to Employee&#8217;s estate and reimburse any outstanding expenses incurred in accordance with this Agreement and shall have no further obligations under this Agreement.  Upon proper termination of this Agreement, Employee shall be entitled to payment of any earned but unpaid compensation for the Consulting Services as of the termination date, and Employee shall not be entitled to any additional or future compensation or any benefits whatsoever.  Employee acknowledges and agrees that, as an independent contractor, he is not entitled to receive unemployment insurance benefits.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%;text-decoration:underline">Consulting Compensation and Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%;text-decoration:underline">Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">.  During the Consulting Period, the Company will pay Employee a monthly fee equal $50,000.00 (the &#8220;Consulting Fees&#8221;).  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%;text-decoration:underline">Taxes and Employee Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">.  During the Consulting Period, Employee shall be serving as an independent contractor of the Company, and therefore unless required by law, the Company shall not deduct any federal, state or local taxes or other withholdings from any sums paid Employee hereunder, and Employee hereby agrees to indemnify and hold harmless the Company and each of its affiliates from any liability for any and all federal, state and local taxes or assessments of any kind arising out of any payment made by the Company to Employee hereunder.  Employee shall be responsible for all tax reporting, tax payments, withholdings, insurance and other payments, expenses and filings required to be made or paid by Employee or Employee&#8217;s agents or employees.  Further, neither Employee nor any of Employee&#8217;s agents or employees on account of having rendered Consulting Services hereunder shall be entitled to any benefits provided by the Company to any of its employees, including, without limitation, any retirement plan, insurance program, disability plan, medical benefits plan or any other fringe benefit program sponsored and maintained by the Company for its employees. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Page 4 of 6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 10.1</font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%;text-decoration:underline">Protection of Confidential Information&#59; Use of Company Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">.  Employee agrees that he will abide by the terms of the Confidentiality Agreement with respect to any Confidential Information (as defined in the Confidentiality Agreement) he learns in connection with providing the Consulting Services under this Agreement.  Employee acknowledges and agrees that any and all materials provided by the Company to Employee that are to be used in connection with Employee&#8217;s provision of the Consulting Services under this Agreement are the property of the Company and may not be used outside of the scope, terms, and conditions of this Agreement or in providing services to or on behalf of any person or entity other than the Company.  Employee agrees that he will immediately return all such materials to the Company on or prior to the end of the Consulting Period, or at any other time the Company requests such return.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">.  This Agreement, the Release Agreement and the Supplemental Release together embody the entire agreement of the Parties relating to the subject matter of this Agreement and supersede all prior agreements, oral or written, regarding the subject matter hereof and as to Separation Benefits to be paid to Employee.  No amendment or modification of this Agreement will be valid or binding upon the Parties unless made in writing and signed by the Parties.</font></div><div style="padding-left:36pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:109%">.  This Agreement shall be governed by and construed in accordance with the laws of the state of Georgia without regard to conflicts of law principles thereof.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Enforcement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The provisions of this Agreement shall be deemed severable, and the invalidity or unenforceability of any provision shall not affect the validity or enforceability of the other provisions hereof.  It is understood and agreed that no failure or delay by Company or Employee in exercising any right, power or privilege under this Agreement shall operate as a waiver thereof, nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege hereunder.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Acknowledgement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Employee agrees that he has read all the terms of this Agreement and understands those terms.  Employee is signing this Agreement of his own free will in exchange for the Separation Benefits, to the extent earned by Employee, to be paid to Employee.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;Signature page follows&#93;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Page 5 of 6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 10.1</font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS HEREOF, Company and Employee have each executed this Agreement as of the date first above written.</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:189pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AVANOS MEDICAL, INC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">., on behalf of itself and its subsidiaries</font></div><div style="padding-left:185.4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:61.698%"><tr><td style="width:1.0%"></td><td style="width:8.770%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:56.042%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.575%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.213%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font><br></font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#47;s&#47; David Pacitti</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">28 April 2025</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Name&#58; David Pacitti</font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Title&#58;   Chief Executive Officer</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="padding-left:185.4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.339%"><tr><td style="width:1.0%"></td><td style="width:7.897%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:57.511%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.013%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.179%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Michael C. Greiner</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">28 April 2025</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Michael C. Greiner</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Page 6 of 6</font></div></div></div><div id="i5174b4401b534ef8aca9ba90d6e9392e_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 10.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXHIBIT A</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AVANOS MEDICAL, INC.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">FULL AND FINAL RELEASE OF CLAIMS AND COVENANT NOT TO SUE</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;This Full and Final Release of Claims and Covenant not to Sue (&#8220;Agreement&#8221;) is made and entered into between Michael C. Greiner (&#8220;Employee&#8221;) and Avanos Medical, Inc., a Delaware corporation (the &#8220;Company&#8221;). </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">SEPARATION FROM EMPLOYMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Employee&#8217;s employment is terminated and Employee&#8217;s last day on the payroll was April 18, 2025 (the &#8220;Separation Date&#8221;).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">SEPARATION BENEFITS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Employee agrees and understands that the consideration described in Section 3 of this Agreement is provided through a Separation and Consulting Agreement between Employee and the Company (the &#8220;Separation Agreement&#8221;), which also requires the execution of this Agreement as a condition to the payment of benefits under the Separation Agreement.   </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">CONSIDERATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In consideration of Employee&#8217;s decision to enter into the Separation Agreement, following the Company&#8217;s receipt of this Agreement executed by the Employee and the expiration of the seven (7) day period within which the Employee may revoke Employee&#8217;s acceptance of this Agreement as explained below (and provided Employee has not exercised such right of revocation), and subject to the terms and conditions of the Separation Agreement, the Company will provide Employee with the Separation Benefits described in Section 4(a) of the Separation Agreement.</font></div><div style="padding-right:18pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employee further acknowledges the Separation Benefits (other than the Consulting Fees) will be subject to reduction to satisfy&#58; (i) all federal, state and local employment and withholding tax obligations to the extent required by law and (ii) any other payroll reductions deemed appropriate by the Company.  Employee agrees that, except for the amounts withheld, Employee shall be fully responsible for paying any taxes, interest, penalties, or other amounts due on the above payments and the Company makes no representation as to the tax treatment of any consideration under this Agreement or the Separation Agreement.  All above payments will be made as provided in the Separation Agreement, provided this Agreement becomes final and binding.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ACKNOWLEDGEMENT REGARDING PAYMENTS AND BENEFITS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Employee acknowledges and agrees that he has been paid all wages and accrued benefits to which he is entitled through the date of execution of this Agreement.  Other than the payments set forth in this Agreement, the parties hereto agree that the Company owes no additional amounts to Employee for wages, back pay, severance pay, bonuses, damages, accrued vacation, benefits, insurance, sick leave, other leave, or any other reason.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">FULL AND FINAL RELEASE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In consideration of the payments being provided to Employee above, Employee, for Employee, Employee&#8217;s attorneys, heirs, executors, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-1-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 10.1</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">administrators, successors and assigns, fully, finally and forever releases and discharges the Company, all parent, subsidiary, related and  affiliated companies, as well as its and their successors, assigns, officers, owners, directors, agents, representatives, attorneys, and employees (all of whom are referred to throughout this Agreement as the &#8220;Released Parties&#8221;), of and from all claims, demands, actions, causes of action, suits, damages, losses, and expenses, whether known or unknown, of any and every nature whatsoever, as a result of actions or omissions occurring through the execution date of this Agreement. Specifically included in this waiver and release are, among other things, any and all claims of alleged employment discrimination, either as a result of the separation of Employee&#8217;s employment or otherwise, any claims under any severance pay plan of the Released Parties, the Age Discrimination in Employment Act, the Older Workers Benefit Protection Act, Title VII of the Civil Rights Act of 1964, the Family and Medical Leave Act (FMLA), the Americans with Disabilities Act, the Worker Adjustment and Retraining Notification (WARN) Act, the Uniformed Services Employment and Reemployment Rights Act (USERRA), the Ledbetter Fair Pay Act, the Genetic Information Nondiscrimination Act of 2008, the Internal Revenue Code (IRC), the US tax code, the Employee Retirement Income Security Act (ERISA), any other federal, state or local statute, rule, ordinance, or regulation, as well as any claims for alleged wrongful discharge, negligent or intentional infliction of emotional distress, breach of contract, fraud, defamation, or any other unlawful behavior, the existence of which is specifically denied by the Released Parties.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the provisions of any law, and for the purpose of implementing a full and complete release and discharge of the Released Parties, Employee expressly acknowledges that this Agreement is intended to include in its effect, without limitation, all claims that Employee does not know or suspect to exist in Employee&#8217;s favor at the time Employee executes this Agreement, and that this Agreement contemplates the extinguishment of any such claims.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The above release does not waive any rights or claims that (a) may arise after the date on which Employee executes this Agreement&#59; (b) cannot lawfully be released under applicable law, including, but not limited to, unemployment benefits and workers&#8217; compensation claims, (c) constitute an award to Employee from or by a Government Agency for providing information.  In addition, nothing in this Agreement is intended to waive any vested right that Employee may have under any pension, 401(k) plan or other benefit plan provided by the Released Parties, and nothing in this Agreement shall prohibit Employee from enforcing such rights.  Further, the above release shall not apply to any obligation of the Company pursuant to the Separation Agreement, any rights in the nature of indemnification which Employee may have, any rights that Employee may have to obtain contribution in the event of the entry of judgment against Employee as a result of any act or failure to act for which both Employee and the Company are jointly responsible or any vested benefit to which Employee is entitled under the Company&#8217;s employee benefit plans.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">COVENANT NOT TO SUE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Except as expressly set forth in Section 7 below, Employee further hereby AGREES NOT TO FILE A LAWSUIT or other legal claim or charge to assert against any of the Released Parties any claim released by this Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-2-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 10.1</font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">NON-INTERFERENCE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Nothing in this Agreement shall be construed to prohibit Employee from filing a charge or participating in any investigation or proceeding before any federal, state or local agency or commission including, but not limited to, the Equal Employment Opportunity Commission, the National Labor Relations Board, the Occupational Safety and Health Administration, and the Securities and Exchange Commission (collectively, &#8220;Government Agencies&#8221;).  In addition, nothing in this Agreement shall limit Employee&#8217;s ability to communicate with any Government Agencies or otherwise participate in any investigation or proceeding that may be conducted by any Government Agency, including providing documents or other information, without notice to the Company.  This Agreement does not limit Employee&#8217;s right to receive an award for information provided to any Government Agencies regarding any violation of any Securities and Exchange Commission regulation or financial fraud or misconduct.  Notwithstanding the foregoing, to the maximum extent permitted by law, Employee waives Employee&#8217;s right to recover damages as a result of any charge or lawsuit filed by Employee or by anyone else on Employee&#8217;s behalf, including a class or collective action, whether or not Employee is named in such proceeding.  Furthermore, pursuant to the federal Defend Trade Secrets Act of 2016, Employee shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made (1) in confidence to a federal, state or local government official, either directly or indirectly, or to an attorney, in each case, solely for the purpose of reporting or investigating a suspected violation of law or (2) in a complaint or other document filed in a lawsuit or proceeding, if such filings are made under seal.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">NO OTHER CLAIMS. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Employee understands that Employee is releasing claims about which Employee may not know anything at the time Employee executes this Agreement. Employee represents and warrants that Employee has (a) filed no claims, lawsuits, charges, grievances, or causes of action of any kind against the Released Parties and, to the best of the Employee&#8217;s knowledge, Employee possesses no such claims (including Fair Labor Standards Act (&#8220;FLSA&#8221;) and worker&#8217;s compensation claims) that Employee has not already disclosed to the Released Parties&#59; (b) received any and all compensation (including overtime compensation), meal periods, and rest periods to which Employee may have been entitled, and Employee is not currently aware of any facts or circumstances constituting a violation by the Released Parties of the FLSA or other applicable wage, hour, meal period, and&#47;or rest period laws that Employee has not already disclosed to the Released Parties&#59; and (c) not suffered any work-related injury or illness within the twelve (12) months preceding Employee&#8217;s execution of this Agreement, and Employee is not currently aware of any facts or circumstances that would give rise to a worker&#8217;s compensation claim against the Released Parties that Employee has not already disclosed to the Released Parties. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">DUTY TO COOPERATE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Employee agrees to be available on a reasonable basis to assist the Released Parties with any investigation, claim, suit, or other proceeding that is pending or threatened by or against the Released Parties.  Employee further agrees to promptly inform the Company&#8217;s General Counsel if Employee is requested to&#58; (a) testify in connection with or otherwise become involved in any claim against the Released Parties&#59; or (b) assist with or participate in any investigation of the Released Parties.  The Company&#8217;s General Counsel may be </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-3-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 10.1</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">contacted via mail at the following address&#58; General Counsel, Avanos Medical, Inc., 5405 Windward Parkway, Alpharetta, Georgia 30004.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">NON-DISPARAGEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Employee agrees that Employee has not and will not (including during the time period while this Agreement was under consideration by Employee) make any defamatory or maliciously disparaging statements about the Released Parties, the Released Parties&#8217; products or services, or the Released Parties&#8217; representatives or employees to current, former or prospective customers or suppliers or other business relations, to the media, or to other members of the public.&#160;&#160; Nothing in this Agreement shall be deemed to preclude the Company or Employee from providing truthful testimony or information pursuant to subpoena, court order, or similar legal process, or from providing truthful information to Government Agencies. The Company will not (including during the time period while this Agreement was under consideration by Employee), and will instruct the Company&#8217;s board of directors and the senior management team of the Company not to, make any defamatory or maliciously disparaging statements about Employee to current, former or prospective employers or other business relations, to the media, or to other members of the public. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">NON-ADMISSION OF LIABILITY OR WRONGFUL CONDUCT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement shall not be construed as an admission by the Released Parties of any liability or acts of wrongdoing or discrimination, nor shall it be considered to be evidence of such liability, wrongdoing, or discrimination. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">TERMINATION OF EMPLOYMENT RELATIONSHIP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Except as set forth above, Employee and the Released Parties agree as a matter of intent that, this Agreement terminates all aspects of the employment relationship between them.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">RETURN OF COMPANY PROPERTY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Employee understands and agrees that all Company Information and Business Ideas (as defined in the Confidentiality, Nonsolicitation and Assignment of Business Ideas Agreement between Employee and the Company) is the exclusive property of the Company and that Employee has no rights in or to the Company Information upon the termination of employment. Employee represents that Employee shall deliver to the Company by the expiration of the Consulting Period&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a) all originals and electronic and paper copies of all documents and records that may contain Company Information in his possession, regardless of where such documents and records are stored including, but not limited to, on USB drives, external hard drives, and&#47;or any cloud-based storage (for which Employee provided any necessary passwords)&#59; </font></div><div style="padding-left:36pt;padding-right:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b) all property of any nature that relates to Company Information or Business Ideas in his possession, including, but not limited to, business activities, customers or prospective customers of the Company, whether prepared by Employee or others&#59; and </font></div><div style="padding-left:36pt;padding-right:36pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-4-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 10.1</font></div></div><div style="padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c) all property of any nature whatsoever that is in Employee&#8217;s possession, custody or control, and that is the property of the Company (e.g. cellular phones, credit cards, computer or other equipment).  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employee further represents that, after returning any electronic copies of documents, records or data to the Company, Employee has made good faith efforts to delete any remaining electronic versions from personal electronic devices (e.g. personal computers, phones, tablets).    </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">GOVERNING LAW&#59; CHOICE OF FORUM</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement shall be governed and construed as to both substantive and procedural matters in accordance with the laws of the State of Georgia, without regard to the conflict of laws principles thereof.  Employee agrees that any claim or dispute Employee may have against the Company must be resolved by a court located in Fulton County, Georgia.  Employee agrees to submit to personal jurisdiction and venue in the Superior Court of Fulton County, State of Georgia for the purpose of litigating all claims or disputes between the Company and Employee.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">SEVERABILITY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The provisions of this Agreement are severable, and if any part of this Agreement is found by a court of law to be unenforceable, the remainder of the Agreement will continue to be valid and effective.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ENTIRE AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement sets forth the entire agreement between Employee and the Company concerning the subject matter of this Agreement and Employee&#8217;s employment with and separation from the Company and the events leading thereto and associated therewith. Any prior agreements between or directly involving Employee and any of the Released Parties concerning the subject matter of this Agreement and Employee&#8217;s relationship with the Company are superseded by the terms of this Agreement and thus are rendered null and void with the exception of the Confidentiality, Nonsolicitation and Assignment of Business Ideas Agreement between Employee and the Company and any other noncompetition, confidentiality, nonsolicitation and&#47;or assignment of business ideas agreements or any prior agreements between the parties related to inventions, business ideas, and confidentiality of corporate information, which remain intact, including, but not limited to, those provided to Employee with this Agreement.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;17.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">NO OTHER PROMISES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Employee affirms that the only consideration for Employee signing this Agreement is that set forth in Section 3, that no other promise or agreement of any kind has been made to or with Employee by any person or entity to cause Employee to execute this document, and that Employee fully understands the meaning and intent of this Agreement, including but not limited to, its final and binding effect.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;18.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">REVIEW AND REVOCATION PERIODS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Employee acknowledges that Employee is hereby advised to consult with an attorney before signing this Agreement.  Employee further acknowledges that Employee has been given twenty-one (21) days from the time that Employee receives this Agreement to consider whether to sign it, as provided by the Age Discrimination in Employment Act of 1967, as amended (ADEA).  If Employee has signed this Agreement before the end of this twenty-one (21) day period, it is because Employee freely </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-5-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 10.1</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">chose to do so after carefully considering its terms.  Finally, Employee shall have seven (7) days from the date Employee signs this Agreement to revoke this Agreement by delivering written notice within the seven (7) day period to the following Company contact&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">General Counsel</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Avanos Medical, Inc.</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5405 Windward Parkway</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Alpharetta, Georgia 30004 </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If Employee does not revoke this Agreement, this Agreement will become effective and irrevocable by Employee on the eighth day after Employee has executed it.  If Employee elects not to sign this Agreement within twenty-one (21) days from the date that Employee receives this Agreement or if the Employee revokes the Agreement during the foregoing applicable revocation period, this Agreement shall not become effective and the offer to enter into this Agreement shall terminate and expire automatically.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">19.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">LEGALLY BINDING AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Employee understands and acknowledges that this Agreement is final and binding following the seven (7) day revocation period provided in this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">REPRESENTATION AND WARRANTY OF UNDERSTANDING</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  By signing below, Employee represents and warrants that Employee&#58; (a) has carefully read and understands the terms of this Agreement&#59; (b) is entering into this Agreement knowingly, voluntarily and of Employee&#8217;s own free will&#59; and (c) understands its terms and significance and intends to abide by its provisions without exception. </font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Michael C. Greiner</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;AVANOS MEDICAL, INC.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Name&#58;&#160;&#160;&#160;&#160;David Pacitti</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Title&#58;&#160;&#160;&#160;&#160;Chief Executive Officer</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-6-</font></div></div></div><div id="i5174b4401b534ef8aca9ba90d6e9392e_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 10.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXHIBIT B</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AVANOS MEDICAL, INC.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">SUPPLEMENTAL RELEASE OF CLAIMS </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;This Supplemental Release of Claims (the &#8220;Supplemental Release&#8221;) is made and entered into by Michael C. Greiner (&#8220;Employee&#8221;) on the date provided below. Capitalized terms not otherwise defined herein shall have the meanings set forth in the Separation and Consulting Agreement dated as of April 28, 2025 by and between Avanos Medical, Inc. (together with its subsidiaries, the &#8220;Company&#8221;) and Employee (the &#8220;Separation Agreement&#8221;) and&#47;or the Full and Final Release of Claims and Covenant Not to Sue by and between Avanos Medical, Inc. and the Employee dated as of April 28, 2025 (the &#8220;Release Agreement&#8221;). Employee must sign this Supplemental Release on (but not before) the Consulting Termination Date or within seven (7) days after the Consulting Termination Date.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">FULL AND FINAL RELEASE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In consideration of the Separation Benefits provided to Employee pursuant to the Separation Agreement and&#47;or the Release Agreement, Employee, for Employee, Employee&#8217;s attorneys, heirs, executors, administrators, successors and assigns, fully, finally and forever releases and discharges the Released Parties of and from all claims, demands, actions, causes of action, suits, damages, losses, and expenses, whether known or unknown, of any and every nature whatsoever, as a result of actions or omissions occurring on or after the date Employee signed the Release Agreement through the execution date of this Supplemental Release. Specifically included in this waiver and release are, among other things, any and all claims of alleged employment discrimination, either as a result of the separation of Employee&#8217;s employment or otherwise, any claims under any severance pay plan of the Released Parties, the Age Discrimination in Employment Act, the Older Workers Benefit Protection Act, Title VII of the Civil Rights Act of 1964, the Family and Medical Leave Act (FMLA), the Americans with Disabilities Act, the Worker Adjustment and Retraining Notification (WARN) Act, the Uniformed Services Employment and Reemployment Rights Act (USERRA), the Ledbetter Fair Pay Act, the Genetic Information Nondiscrimination Act of 2008, the Internal Revenue Code (IRC), the US tax code, the Employee Retirement Income Security Act (ERISA), any other federal, state or local statute, rule, ordinance, or regulation, as well as any claims for alleged wrongful discharge, negligent or intentional infliction of emotional distress, breach of contract, fraud, defamation, or any other unlawful behavior, the existence of which is specifically denied by the Released Parties.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the provisions of any law, and for the purpose of implementing a full and complete release and discharge of the Released Parties, Employee expressly acknowledges that this Supplemental Release is intended to include in its effect, without limitation, all claims that Employee does not know or suspect to exist in Employee&#8217;s favor at the time Employee executes this Supplemental Release, and that this Supplemental Release contemplates the extinguishment of any such claims.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-1-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 10.1</font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The above release does not waive any rights or claims that (a) may arise after the date on which Employee executes this Supplemental Release&#59; (b) cannot lawfully be released under applicable law, including, but not limited to, unemployment benefits and workers&#8217; compensation claims, (c) constitute an award to Employee from or by a Government Agency for providing information.  In addition, nothing in this Supplemental Release is intended to waive any vested right that Employee may have under any pension, 401(k) plan or other benefit plan provided by the Released Parties, and nothing in this Supplemental Release shall prohibit Employee from enforcing such rights.  Further, the above release shall not apply to any obligation of the Company pursuant to the Separation Agreement, any rights in the nature of indemnification which Employee may have, any rights that Employee may have to obtain contribution in the event of the entry of judgment against Employee as a result of any act or failure to act for which both Employee and the Company are jointly responsible or any vested benefit to which Employee is entitled under the Company&#8217;s employee benefit plans.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">COVENANT NOT TO SUE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Except as expressly set forth in Section 3 below, Employee further hereby AGREES NOT TO FILE A LAWSUIT or other legal claim or charge to assert against any of the Released Parties any claim released by this Supplemental Release.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">NON-INTERFERENCE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Nothing in this Supplemental Release shall be construed to prohibit Employee from filing a charge or participating in any investigation or proceeding before any Government Agencies.  In addition, nothing in this Supplemental Release shall limit Employee&#8217;s ability to communicate with any Government Agencies or otherwise participate in any investigation or proceeding that may be conducted by any Government Agency, including providing documents or other information, without notice to the Company.  This Supplemental Release does not limit Employee&#8217;s right to receive an award for information provided to any Government Agencies regarding any violation of any Securities and Exchange Commission regulation or financial fraud or misconduct.  Notwithstanding the foregoing, to the maximum extent permitted by law, Employee waives Employee&#8217;s right to recover damages as a result of any charge or lawsuit filed by Employee or by anyone else on Employee&#8217;s behalf, including a class or collective action, whether or not Employee is named in such proceeding.  Furthermore, pursuant to the federal Defend Trade Secrets Act of 2016, Employee shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made (1) in confidence to a federal, state or local government official, either directly or indirectly, or to an attorney, in each case, solely for the purpose of reporting or investigating a suspected violation of law or (2) in a complaint or other document filed in a lawsuit or proceeding, if such filings are made under seal.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">NO OTHER CLAIMS. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Employee understands that Employee is releasing claims about which Employee may not know anything at the time Employee executes this Supplemental Release. Employee represents and warrants that Employee has (a) filed no claims, lawsuits, charges, grievances, or causes of action of any kind against the Released Parties and, to the best of the Employee&#8217;s knowledge, Employee possesses no such claims (including Fair Labor Standards Act (&#8220;FLSA&#8221;) and worker&#8217;s compensation claims) that Employee has not already disclosed to the Released Parties&#59; (b) received any and all compensation (including overtime compensation), meal periods, and rest periods to which Employee may have been entitled, and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-2-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 10.1</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employee is not currently aware of any facts or circumstances constituting a violation by the Released Parties of the FLSA or other applicable wage, hour, meal period, and&#47;or rest period laws that Employee has not already disclosed to the Released Parties&#59; and (c) not suffered any work-related injury or illness within the twelve (12) months preceding Employee&#8217;s execution of this Supplemental Release, and Employee is not currently aware of any facts or circumstances that would give rise to a worker&#8217;s compensation claim against the Released Parties that Employee has not already disclosed to the Released Parties. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">REVIEW AND REVOCATION PERIODS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Employee acknowledges that Employee is hereby advised to consult with an attorney before signing this Supplemental Release.  Employee further acknowledges that Employee has been given twenty-one (21) days from the time that Employee receives this Supplemental Release to consider whether to sign it, as provided by the Age Discrimination in Employment Act of 1967, as amended (ADEA).  If Employee has signed this Supplemental Release before the end of this twenty-one (21) day period, it is because Employee freely chose to do so after carefully considering its terms.  Employee may not sign this Supplemental Release prior to the Consulting Termination Date. Finally, Employee shall have seven (7) days from the date Employee signs this Supplemental Release to revoke this Supplemental Release by delivering written notice within the seven (7) day period to the following Company contact&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">General Counsel</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Avanos Medical, Inc.</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5405 Windward Parkway</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Alpharetta, Georgia 30004 </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If Employee does not revoke this Supplemental Release, this Supplemental Release will become effective and irrevocable by Employee on the eighth day after Employee has executed it.  If Employee elects not to sign this Supplemental Release within seven (7) days from the Consulting Termination Date or if the Employee revokes the Supplemental Release during the foregoing applicable revocation period, this Supplemental Release shall not become effective and the offer to enter into this Supplemental Release shall terminate and expire automatically.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">LEGALLY BINDING AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Employee understands and acknowledges that this Supplemental Release is final and binding following the seven (7) day revocation period provided in this Supplemental Release.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">REPRESENTATION AND WARRANTY OF UNDERSTANDING</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  By signing below, Employee represents and warrants that Employee&#58; (a) has carefully read and understands the terms of this Supplemental Release&#59; (b) is entering into this Supplemental Release knowingly, voluntarily and of Employee&#8217;s own free will&#59; and (c) understands its terms and significance and intends to abide by its provisions without exception. </font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Michael C. Greiner</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-3-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXHIBIT 10.1</font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-4-</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>3
<FILENAME>avnsform8k_04282025xex102.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i44b42f8d5f144976916b35ef50106ddc_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT 10.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">AVANOS MEDICAL, INC.</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%;text-decoration:underline">FULL AND FINAL RELEASE OF CLAIMS AND COVENANT NOT TO SUE</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;This Full and Final Release of Claims and Covenant not to Sue (&#8220;Agreement&#8221;) is made and entered into between Michael C. Greiner (&#8220;Employee&#8221;) and Avanos Medical, Inc., a Delaware corporation (the &#8220;Company&#8221;). </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">SEPARATION FROM EMPLOYMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Employee&#8217;s employment is terminated and Employee&#8217;s last day on the payroll was April 18, 2025 (the &#8220;Separation Date&#8221;).</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">SEPARATION BENEFITS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Employee agrees and understands that the consideration described in Section 3 of this Agreement is provided through a Separation and Consulting Agreement between Employee and the Company (the &#8220;Separation Agreement&#8221;), which also requires the execution of this Agreement as a condition to the payment of benefits under the Separation Agreement.   </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">CONSIDERATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In consideration of Employee&#8217;s decision to enter into the Separation Agreement, following the Company&#8217;s receipt of this Agreement executed by the Employee and the expiration of the seven (7) day period within which the Employee may revoke Employee&#8217;s acceptance of this Agreement as explained below (and provided Employee has not exercised such right of revocation), and subject to the terms and conditions of the Separation Agreement, the Company will provide Employee with the Separation Benefits described in Section 4(a) of the Separation Agreement.</font></div><div style="padding-right:18pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employee further acknowledges the Separation Benefits (other than the Consulting Fees) will be subject to reduction to satisfy&#58; (i) all federal, state and local employment and withholding tax obligations to the extent required by law and (ii) any other payroll reductions deemed appropriate by the Company.  Employee agrees that, except for the amounts withheld, Employee shall be fully responsible for paying any taxes, interest, penalties, or other amounts due on the above payments and the Company makes no representation as to the tax treatment of any consideration under this Agreement or the Separation Agreement.  All above payments will be made as provided in the Separation Agreement, provided this Agreement becomes final and binding.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ACKNOWLEDGEMENT REGARDING PAYMENTS AND BENEFITS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Employee acknowledges and agrees that he has been paid all wages and accrued benefits to which he is entitled through the date of execution of this Agreement.  Other than the payments set forth in this Agreement, the parties hereto agree that the Company owes no additional amounts to Employee for wages, back pay, severance pay, bonuses, damages, accrued vacation, benefits, insurance, sick leave, other leave, or any other reason.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">FULL AND FINAL RELEASE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  In consideration of the payments being provided to Employee above, Employee, for Employee, Employee&#8217;s attorneys, heirs, executors, administrators, successors and assigns, fully, finally and forever releases and discharges the Company, all parent, subsidiary, related and  affiliated companies, as well as its and their </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-1-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT 10.2</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">successors, assigns, officers, owners, directors, agents, representatives, attorneys, and employees (all of whom are referred to throughout this Agreement as the &#8220;Released Parties&#8221;), of and from all claims, demands, actions, causes of action, suits, damages, losses, and expenses, whether known or unknown, of any and every nature whatsoever, as a result of actions or omissions occurring through the execution date of this Agreement. Specifically included in this waiver and release are, among other things, any and all claims of alleged employment discrimination, either as a result of the separation of Employee&#8217;s employment or otherwise, any claims under any severance pay plan of the Released Parties, the Age Discrimination in Employment Act, the Older Workers Benefit Protection Act, Title VII of the Civil Rights Act of 1964, the Family and Medical Leave Act (FMLA), the Americans with Disabilities Act, the Worker Adjustment and Retraining Notification (WARN) Act, the Uniformed Services Employment and Reemployment Rights Act (USERRA), the Ledbetter Fair Pay Act, the Genetic Information Nondiscrimination Act of 2008, the Internal Revenue Code (IRC), the US tax code, the Employee Retirement Income Security Act (ERISA), any other federal, state or local statute, rule, ordinance, or regulation, as well as any claims for alleged wrongful discharge, negligent or intentional infliction of emotional distress, breach of contract, fraud, defamation, or any other unlawful behavior, the existence of which is specifically denied by the Released Parties.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the provisions of any law, and for the purpose of implementing a full and complete release and discharge of the Released Parties, Employee expressly acknowledges that this Agreement is intended to include in its effect, without limitation, all claims that Employee does not know or suspect to exist in Employee&#8217;s favor at the time Employee executes this Agreement, and that this Agreement contemplates the extinguishment of any such claims.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The above release does not waive any rights or claims that (a) may arise after the date on which Employee executes this Agreement&#59; (b) cannot lawfully be released under applicable law, including, but not limited to, unemployment benefits and workers&#8217; compensation claims, (c) constitute an award to Employee from or by a Government Agency for providing information.  In addition, nothing in this Agreement is intended to waive any vested right that Employee may have under any pension, 401(k) plan or other benefit plan provided by the Released Parties, and nothing in this Agreement shall prohibit Employee from enforcing such rights.  Further, the above release shall not apply to any obligation of the Company pursuant to the Separation Agreement, any rights in the nature of indemnification which Employee may have, any rights that Employee may have to obtain contribution in the event of the entry of judgment against Employee as a result of any act or failure to act for which both Employee and the Company are jointly responsible or any vested benefit to which Employee is entitled under the Company&#8217;s employee benefit plans.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">COVENANT NOT TO SUE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Except as expressly set forth in Section 7 below, Employee further hereby AGREES NOT TO FILE A LAWSUIT or other legal claim or charge to assert against any of the Released Parties any claim released by this Agreement.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">NON-INTERFERENCE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Nothing in this Agreement shall be construed to prohibit Employee from filing a charge or participating in any investigation or proceeding before any federal, state or local agency or commission including, but not limited to, the Equal </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-2-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT 10.2</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employment Opportunity Commission, the National Labor Relations Board, the Occupational Safety and Health Administration, and the Securities and Exchange Commission (collectively, &#8220;Government Agencies&#8221;).  In addition, nothing in this Agreement shall limit Employee&#8217;s ability to communicate with any Government Agencies or otherwise participate in any investigation or proceeding that may be conducted by any Government Agency, including providing documents or other information, without notice to the Company.  This Agreement does not limit Employee&#8217;s right to receive an award for information provided to any Government Agencies regarding any violation of any Securities and Exchange Commission regulation or financial fraud or misconduct.  Notwithstanding the foregoing, to the maximum extent permitted by law, Employee waives Employee&#8217;s right to recover damages as a result of any charge or lawsuit filed by Employee or by anyone else on Employee&#8217;s behalf, including a class or collective action, whether or not Employee is named in such proceeding.  Furthermore, pursuant to the federal Defend Trade Secrets Act of 2016, Employee shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that is made (1) in confidence to a federal, state or local government official, either directly or indirectly, or to an attorney, in each case, solely for the purpose of reporting or investigating a suspected violation of law or (2) in a complaint or other document filed in a lawsuit or proceeding, if such filings are made under seal.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">NO OTHER CLAIMS. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  Employee understands that Employee is releasing claims about which Employee may not know anything at the time Employee executes this Agreement. Employee represents and warrants that Employee has (a) filed no claims, lawsuits, charges, grievances, or causes of action of any kind against the Released Parties and, to the best of the Employee&#8217;s knowledge, Employee possesses no such claims (including Fair Labor Standards Act (&#8220;FLSA&#8221;) and worker&#8217;s compensation claims) that Employee has not already disclosed to the Released Parties&#59; (b) received any and all compensation (including overtime compensation), meal periods, and rest periods to which Employee may have been entitled, and Employee is not currently aware of any facts or circumstances constituting a violation by the Released Parties of the FLSA or other applicable wage, hour, meal period, and&#47;or rest period laws that Employee has not already disclosed to the Released Parties&#59; and (c) not suffered any work-related injury or illness within the twelve (12) months preceding Employee&#8217;s execution of this Agreement, and Employee is not currently aware of any facts or circumstances that would give rise to a worker&#8217;s compensation claim against the Released Parties that Employee has not already disclosed to the Released Parties. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">DUTY TO COOPERATE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Employee agrees to be available on a reasonable basis to assist the Released Parties with any investigation, claim, suit, or other proceeding that is pending or threatened by or against the Released Parties.  Employee further agrees to promptly inform the Company&#8217;s General Counsel if Employee is requested to&#58; (a) testify in connection with or otherwise become involved in any claim against the Released Parties&#59; or (b) assist with or participate in any investigation of the Released Parties.  The Company&#8217;s General Counsel may be contacted via mail at the following address&#58; General Counsel, Avanos Medical, Inc., 5405 Windward Parkway, Alpharetta, Georgia 30004.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-3-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT 10.2</font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">NON-DISPARAGEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Employee agrees that Employee has not and will not (including during the time period while this Agreement was under consideration by Employee) make any defamatory or maliciously disparaging statements about the Released Parties, the Released Parties&#8217; products or services, or the Released Parties&#8217; representatives or employees to current, former or prospective customers or suppliers or other business relations, to the media, or to other members of the public.&#160;&#160; Nothing in this Agreement shall be deemed to preclude the Company or Employee from providing truthful testimony or information pursuant to subpoena, court order, or similar legal process, or from providing truthful information to Government Agencies. The Company will not (including during the time period while this Agreement was under consideration by Employee), and will instruct the Company&#8217;s board of directors and the senior management team of the Company not to, make any defamatory or maliciously disparaging statements about Employee to current, former or prospective employers or other business relations, to the media, or to other members of the public. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">NON-ADMISSION OF LIABILITY OR WRONGFUL CONDUCT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement shall not be construed as an admission by the Released Parties of any liability or acts of wrongdoing or discrimination, nor shall it be considered to be evidence of such liability, wrongdoing, or discrimination. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">TERMINATION OF EMPLOYMENT RELATIONSHIP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Except as set forth above, Employee and the Released Parties agree as a matter of intent that, this Agreement terminates all aspects of the employment relationship between them.  </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">RETURN OF COMPANY PROPERTY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Employee understands and agrees that all Company Information and Business Ideas (as defined in the Confidentiality, Nonsolicitation and Assignment of Business Ideas Agreement between Employee and the Company) is the exclusive property of the Company and that Employee has no rights in or to the Company Information upon the termination of employment. Employee represents that Employee shall deliver to the Company by the expiration of the Consulting Period&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a) all originals and electronic and paper copies of all documents and records that may contain Company Information in his possession, regardless of where such documents and records are stored including, but not limited to, on USB drives, external hard drives, and&#47;or any cloud-based storage (for which Employee provided any necessary passwords)&#59; </font></div><div style="padding-left:36pt;padding-right:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b) all property of any nature that relates to Company Information or Business Ideas in his possession, including, but not limited to, business activities, customers or prospective customers of the Company, whether prepared by Employee or others&#59; and </font></div><div style="padding-left:36pt;padding-right:36pt;text-align:justify"><font><br></font></div><div style="padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c) all property of any nature whatsoever that is in Employee&#8217;s possession, custody or control, and that is the property of the Company (e.g. cellular phones, credit cards, computer or other equipment).  </font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-4-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT 10.2</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Employee further represents that, after returning any electronic copies of documents, records or data to the Company, Employee has made good faith efforts to delete any remaining electronic versions from personal electronic devices (e.g. personal computers, phones, tablets).    </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">GOVERNING LAW&#59; CHOICE OF FORUM</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement shall be governed and construed as to both substantive and procedural matters in accordance with the laws of the State of Georgia, without regard to the conflict of laws principles thereof.  Employee agrees that any claim or dispute Employee may have against the Company must be resolved by a court located in Fulton County, Georgia.  Employee agrees to submit to personal jurisdiction and venue in the Superior Court of Fulton County, State of Georgia for the purpose of litigating all claims or disputes between the Company and Employee.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">SEVERABILITY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  The provisions of this Agreement are severable, and if any part of this Agreement is found by a court of law to be unenforceable, the remainder of the Agreement will continue to be valid and effective.  </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">16.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">ENTIRE AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  This Agreement sets forth the entire agreement between Employee and the Company concerning the subject matter of this Agreement and Employee&#8217;s employment with and separation from the Company and the events leading thereto and associated therewith. Any prior agreements between or directly involving Employee and any of the Released Parties concerning the subject matter of this Agreement and Employee&#8217;s relationship with the Company are superseded by the terms of this Agreement and thus are rendered null and void with the exception of the Confidentiality, Nonsolicitation and Assignment of Business Ideas Agreement between Employee and the Company and any other noncompetition, confidentiality, nonsolicitation and&#47;or assignment of business ideas agreements or any prior agreements between the parties related to inventions, business ideas, and confidentiality of corporate information, which remain intact, including, but not limited to, those provided to Employee with this Agreement.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;17.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">NO OTHER PROMISES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Employee affirms that the only consideration for Employee signing this Agreement is that set forth in Section 3, that no other promise or agreement of any kind has been made to or with Employee by any person or entity to cause Employee to execute this document, and that Employee fully understands the meaning and intent of this Agreement, including but not limited to, its final and binding effect.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;18.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">REVIEW AND REVOCATION PERIODS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Employee acknowledges that Employee is hereby advised to consult with an attorney before signing this Agreement.  Employee further acknowledges that Employee has been given twenty-one (21) days from the time that Employee receives this Agreement to consider whether to sign it, as provided by the Age Discrimination in Employment Act of 1967, as amended (ADEA).  If Employee has signed this Agreement before the end of this twenty-one (21) day period, it is because Employee freely chose to do so after carefully considering its terms.  Finally, Employee shall have seven (7) days from the date Employee signs this Agreement to revoke this Agreement by delivering written notice within the seven (7) day period to the following Company contact&#58;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-5-</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">EXHIBIT 10.2</font></div></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">General Counsel</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Avanos Medical, Inc.</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5405 Windward Parkway</font></div><div style="padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Alpharetta, Georgia 30004 </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If Employee does not revoke this Agreement, this Agreement will become effective and irrevocable by Employee on the eighth day after Employee has executed it.  If Employee elects not to sign this Agreement within twenty-one (21) days from the date that Employee receives this Agreement or if the Employee revokes the Agreement during the foregoing applicable revocation period, this Agreement shall not become effective and the offer to enter into this Agreement shall terminate and expire automatically.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">19.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">LEGALLY BINDING AGREEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  Employee understands and acknowledges that this Agreement is final and binding following the seven (7) day revocation period provided in this Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">20.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">REPRESENTATION AND WARRANTY OF UNDERSTANDING</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  By signing below, Employee represents and warrants that Employee&#58; (a) has carefully read and understands the terms of this Agreement&#59; (b) is entering into this Agreement knowingly, voluntarily and of Employee&#8217;s own free will&#59; and (c) understands its terms and significance and intends to abide by its provisions without exception. </font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date&#58;&#160;&#160;&#160;&#160;28 April 2025&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Michael C. Greiner&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Michael C. Greiner</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;AVANOS MEDICAL, INC.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date&#58;&#160;&#160;&#160;&#160;28 April 2025&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; David Pacitti&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Name&#58;&#160;&#160;&#160;&#160;David Pacitti</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Title&#58;&#160;&#160;&#160;&#160;Chief Executive Officer</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">-6-</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>avns-20250428.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:e3e68b24-25c3-42c3-996b-ac20c52bbb64,g:48bf99d9-a070-4f97-943f-5a2790fc18d0-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:avns="http://www.avanos.com/20250428" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.avanos.com/20250428">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="avns-20250428_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="avns-20250428_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.avanos.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>avns-20250428_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:e3e68b24-25c3-42c3-996b-ac20c52bbb64,g:48bf99d9-a070-4f97-943f-5a2790fc18d0-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_d87a0f9f-cd97-4f6f-ae11-dbea375a691f_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_3f9a0b6f-2bad-4116-a020-96ed39f35026_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_7b510baf-b3d5-47e2-88f2-746bf62f72a8_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_b970e8ee-d54b-467b-800c-3cba07363eda_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_63526ade-29c0-4e80-9f6b-eb429a6e8310_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_5ff2f1df-cb9e-4079-bcc6-86daec45385f_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_1c56ce46-a700-4678-ab43-9d4b989fe8e7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_9a263d87-538c-48d5-aa67-cc223ff9c12b_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_4f44cf91-d598-42c9-a969-c0322bb28236_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_9b61413e-00cc-4674-b157-4bd56618c7b9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_c9556bdc-0b8f-4a5e-a46b-65bcb2c3319d_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_948f336b-6a52-475d-832a-8d54cd5e5bb3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_93a9092e-ff99-4e32-93e5-faa242e739df_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_372cb398-c690-4277-ae4e-8438d4054aae_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_47d57bf2-2967-40da-b7b9-f554b461178d_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_428eb4de-d8d8-4cbe-9f64-88186d24bae7_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_673bba40-05cf-4818-8ade-0db1365ea2f1_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_efea295b-ea62-456d-8fd6-c2d5b662f56c_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_af449727-8570-4299-bb90-b3ac0f12af67_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_70696463-ecc9-453c-80ea-e8c6ba963396_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_63e6293a-a4a3-4f09-8671-4d495a86b9f0_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_f490400b-a2b5-48a7-a20e-1cc0ab7123e8_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_b9eefd1a-76b3-458f-8b05-336fa108fedd_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>avns-20250428_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:e3e68b24-25c3-42c3-996b-ac20c52bbb64,g:48bf99d9-a070-4f97-943f-5a2790fc18d0-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.avanos.com/role/Cover" xlink:type="simple" xlink:href="avns-20250428.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.avanos.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_13a8e1d4-f561-4a30-b094-958431e01efe" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_677c5172-8c7f-4f24-be16-f233a84597f0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_13a8e1d4-f561-4a30-b094-958431e01efe" xlink:to="loc_dei_DocumentType_677c5172-8c7f-4f24-be16-f233a84597f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_681a090e-6b12-4363-bcf9-0d2c0159431f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_13a8e1d4-f561-4a30-b094-958431e01efe" xlink:to="loc_dei_EntityFileNumber_681a090e-6b12-4363-bcf9-0d2c0159431f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_b38fb1e7-fed1-47e0-a9cb-f1453e30670f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_13a8e1d4-f561-4a30-b094-958431e01efe" xlink:to="loc_dei_EntityRegistrantName_b38fb1e7-fed1-47e0-a9cb-f1453e30670f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_664c2563-a463-4dcd-906d-8aa2d95e47d6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_13a8e1d4-f561-4a30-b094-958431e01efe" xlink:to="loc_dei_EntityIncorporationStateCountryCode_664c2563-a463-4dcd-906d-8aa2d95e47d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_414d504d-7e5a-4919-b482-2b937a8ee715" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_13a8e1d4-f561-4a30-b094-958431e01efe" xlink:to="loc_dei_EntityTaxIdentificationNumber_414d504d-7e5a-4919-b482-2b937a8ee715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_6a95415d-49f3-4980-af7c-b581328d152d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_13a8e1d4-f561-4a30-b094-958431e01efe" xlink:to="loc_dei_EntityAddressAddressLine1_6a95415d-49f3-4980-af7c-b581328d152d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_6b254130-0802-45a2-af28-5cc8312a0759" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_13a8e1d4-f561-4a30-b094-958431e01efe" xlink:to="loc_dei_EntityAddressAddressLine2_6b254130-0802-45a2-af28-5cc8312a0759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_aa46f0c1-645f-4b2f-b859-6211c5e3437e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_13a8e1d4-f561-4a30-b094-958431e01efe" xlink:to="loc_dei_EntityAddressStateOrProvince_aa46f0c1-645f-4b2f-b859-6211c5e3437e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_a692bcf1-0c67-429e-b417-85cccdd2e7d0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_13a8e1d4-f561-4a30-b094-958431e01efe" xlink:to="loc_dei_EntityAddressCityOrTown_a692bcf1-0c67-429e-b417-85cccdd2e7d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_f7b2c506-1c77-4af8-8541-942703994aed" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_13a8e1d4-f561-4a30-b094-958431e01efe" xlink:to="loc_dei_EntityAddressPostalZipCode_f7b2c506-1c77-4af8-8541-942703994aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_99b2571d-3765-46cf-a7a0-d8388ebcd422" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_13a8e1d4-f561-4a30-b094-958431e01efe" xlink:to="loc_dei_LocalPhoneNumber_99b2571d-3765-46cf-a7a0-d8388ebcd422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_35d81dda-e516-4e62-a1c1-9a2d37b8ce56" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_13a8e1d4-f561-4a30-b094-958431e01efe" xlink:to="loc_dei_WrittenCommunications_35d81dda-e516-4e62-a1c1-9a2d37b8ce56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_bf042a50-c0a3-4aec-8e47-dfa356f39184" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_13a8e1d4-f561-4a30-b094-958431e01efe" xlink:to="loc_dei_SolicitingMaterial_bf042a50-c0a3-4aec-8e47-dfa356f39184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_aab14c18-df46-4ced-8e4f-706f419fdc91" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_13a8e1d4-f561-4a30-b094-958431e01efe" xlink:to="loc_dei_PreCommencementTenderOffer_aab14c18-df46-4ced-8e4f-706f419fdc91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_bd0f95d6-590b-4987-bb53-f46b5fa15bd8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_13a8e1d4-f561-4a30-b094-958431e01efe" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_bd0f95d6-590b-4987-bb53-f46b5fa15bd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_74bc80f8-adbb-4a27-876a-4b8620ce09fe" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_13a8e1d4-f561-4a30-b094-958431e01efe" xlink:to="loc_dei_Security12bTitle_74bc80f8-adbb-4a27-876a-4b8620ce09fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_aee1416a-e9ac-4ebc-b5c6-bad77a5262b3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_13a8e1d4-f561-4a30-b094-958431e01efe" xlink:to="loc_dei_TradingSymbol_aee1416a-e9ac-4ebc-b5c6-bad77a5262b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_c06e9b4d-f9b7-4b06-a1af-94ddff33b77e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_13a8e1d4-f561-4a30-b094-958431e01efe" xlink:to="loc_dei_SecurityExchangeName_c06e9b4d-f9b7-4b06-a1af-94ddff33b77e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_f9934e19-fdca-4489-a722-098714f30041" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_13a8e1d4-f561-4a30-b094-958431e01efe" xlink:to="loc_dei_EntityEmergingGrowthCompany_f9934e19-fdca-4489-a722-098714f30041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_d8837184-de42-43d6-841d-ad6cfbdbe30c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_13a8e1d4-f561-4a30-b094-958431e01efe" xlink:to="loc_dei_EntityCentralIndexKey_d8837184-de42-43d6-841d-ad6cfbdbe30c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_8dbd7039-819d-4f1d-84d0-3e626340f6e1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_13a8e1d4-f561-4a30-b094-958431e01efe" xlink:to="loc_dei_AmendmentFlag_8dbd7039-819d-4f1d-84d0-3e626340f6e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_b88dbf5d-cfc1-41fd-add4-7526bb553e58" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_13a8e1d4-f561-4a30-b094-958431e01efe" xlink:to="loc_dei_DocumentPeriodEndDate_b88dbf5d-cfc1-41fd-add4-7526bb553e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_715a6b2d-3c9b-4bad-866f-aa2dc134fb57" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_13a8e1d4-f561-4a30-b094-958431e01efe" xlink:to="loc_dei_CityAreaCode_715a6b2d-3c9b-4bad-866f-aa2dc134fb57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>avns-20250428_g1.jpg
<TEXT>
begin 644 avns-20250428_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_[@ .061O8F4 9      !_^$ AD5X:68
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M 1$  A$! Q$!_\0 'P   @(" P$! 0            H)"P<( P0%!@(!_\0
M6!    8! P(# P0)#0L- 0   0(#! 4&!P 1"!()(1,*,4$442(5%S)"M-26
M5W=X.6%QL7*2LB,S);75%EA2<[,D='6V-Q@X&H'!8H)#4\/C-(0UAD@9_\0
M&0$  P$! 0                ,$ @$%_\0 )!$  @,  @(# 0$! 0$
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MQGJQ9H9?X:5A)ABAU).$%-AZ#IF\0';6;^$S5/+17>?_ -;>Y5_;/SE^%/\
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M)$U#@R]KIP- "O\ ZGOBP.0^-.,^4<!&F<6' EK-5[:X;IJ*+#CC(YTDBJ*
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M RK&2<;-1S"8AY!C+1,HS;2$9*1CM-_'2+!X0%$5T%TC'26353,!B'(80$!
M0';5 D[V@"OX]25RO/FSFLQP/!2BKFD\8*V2MN6J2RGP*N3+@1"0FEN@1\LQ
MV[8&30Q@#P,D<N_MU%O:7'T595A21F]LGBTXYB\WL"X259KNJJ_MS>U9&41
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MS5JA>DF'4=1$IA\T6,H4IG#%0WM+U)B(J)*;6]^]6R;KTLBOEU"5%B[Z<_\
M1;XK_*)F3^?W>KL/R2:_HG/TX603>HUISJT=L/(,JT167-1,EXHMK@B*9E#%
M9*2A8I4X@4!V*F$F!S"/@  (CX:3NO\ R,R?DKK-0E99_P#9WR3#Y1[:'$";
MAW)7)8#$D/CJ3 !W.A-XS.K NR'#V@/FL!-X^T! ?8(:]#)S5$>BALDMTPP&
M@ T &@"N4]0]D>&R!W/,I,85?XDF-J3C;'$DH!1 A9F-CPD'*8#[#>4I)^6(
MA[P$/: AJ'=S8JR4(Q!V.::]NO=(XHM&:)E"0-HM%R>J 03$;,JE 2KT3G'V
M% 3I%( C]L8 ]^N8J;([I^6696KR0- '"X;H.T%VKI!%RU<HJ-W+9PF59!P@
ML42G(<A@$IRG*(@("&PAH @QYB^GUX+<H'$Q:Z+"R7&;)LF9=T>P8G;HEI+^
M15ZS>8^JZW3'& RA^H_P)VIS#]D<=)O@K?\ !E=7458YI]A;G'Q#CYBZ0]>C
M^0^)XDJKIW=L1(+O9V'CDP,85Y2N*E&4:E(F03*J-@<(IAXF5 /'4U\;5'5U
M5B$X0$!$!#80\! ? 0$-*&C/OI[>Z+<<3YCJ_"+,=F=S6%LKOAA<1/)R0\PV
M+<D.=S-6#958VY(^=. MP; .Q')DC)@7S%>JC#2'#$ZTE2.<\GL[5KC'QZS%
MGZVJIDA,54&?MAT%%01&4DV2(ECV!#" @"DC('0:I;_;G+JJUNJDG2EP5.U^
MN]CR9>KED:X/AD[9?;3/W*RR EZ/C9ZS.E7CM4"[CT@==8P@7?P#PUYS<EJ4
M#CWI;>*(PU(S;S(L<6!'MS?DPQC-XX3(*@5JOG1?3[E P'$X$=R/PK<>HH?.
M;&VU5Z]?D1M;X&X=4B#Y>[TZOY#IMKH-L8)2E7NM<FJK88Y8I3IOH6?;*-7*
M0@8IB_/15, ;@.N-2"\%3]RNP#8>+?([,O'^SD5^DL77V>K*#M4ABA+0C=83
MQSX@G(F)B/H\Z*Y3 4 $#>'AKSK5ZN"VKE2,,>E]Y7#1L]Y5XEV*1.2 S77@
MOM$;K*"*#?(M!3-\8BF!C@4@R,(<YSB!1$PMDPT[U[0X%;5GR/(ZL)PT >)9
MJY"W&MV"HV6/;RU=M,)+5R?BG9/,:R<+.(*-73=4OVQ%D%3$,'R#HY#@J?N7
M_'Z9XK<GLX<?)P%!<XNR%.5^/<+"4RLE65#@ZAWANGYH"^B7#9QL'LZ]M>;:
MO5P6U?922 ]F#N(17;\S5F"<NJZQL>9'PC<6SF.22%7XO)-%:.9:K%\ -TB\
M=%7CBCML!G)1,(%*(ZWE?HS.E.Q$K=[C/Y$N=NO]K>C(VB\6:>M]DD!+T"^G
MK(Z5>.UMO';S'"QS;>[?2VY-KP-7>EKXM%G<B9RY?V"-358T2);X;QRZ6*!Q
M):;.5-_.N4P$-R':QA6K<IRCXE<J%_7H]>O+$[/X'5]5DX: -).XQRC9\..&
M6=L\&=)M[#7::]A\?I'4\L[S(]J_DZ$(7^#5W\M\X(L<!+MT$-OMK%[=$V:H
MNS@JN'[YW)OGDE(.%7;^0=.'SYVN;K6=.W9Q454./O,<YA$1^77G%H^5Z9CB
MD&*N)-PY*V&+*WM?)"UJMZVY7;D^*2Q=CQ1=DV,13^,(5],&?',0? 2II&\=
MPVL]>L*2;:TN!EC5 DPQR*PI5^1V"<M8)N2":U=RK0[%3'JBB0+&8+2[<Y&S
MU,IO#S6#KRW*(^XY"C[M<LNR@ZG#DJ<<F8]LV),BWO%MT9#'VW'5NL5*LC/Y
MW0A-5EVJS< 03%*)B"JB(D-M\XNPAX#KS6H+4Y&[/2U\L!79YQX9663$5& I
M9OQ:U<+F.(LW!D8ZR-$2B7I(5)86#DI0-N(J*FV\!'5/KVY0C:OR.$ZJ$!H
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MA1N0 (,VF$^:CJ:QX8H?GGBGR0XP3RU<S]A;(6+)!)Q\*DO:*\LW@Y%7;?\
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E\# _Y\;?X74M.2E\%F'@G_5/2?\ ,;#_  1->@B-\F7-=.'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Apr. 28, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AVANOS MEDICAL, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-4987888<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5405 Windward Parkway<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100 South<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">GA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Alpharetta,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">30004<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">428-2667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock - $0.01 Par Value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AVNS<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001606498<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 28,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">844<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( /5-GEI&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( /5-GEK0O#LV[@   "L"   1
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MM5II ,,X?<D3$L/<@HL(2W@4R]9<X%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A
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M#RP/9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q
M_G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"
MIQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04    " #U39Y:EXJ[',
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MZ8Y>9WK_,'G4'EKG5LJ]AU>RY1AQ_)[E#U!+ P04    " #U39Y:)!Z;HJT
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M2P$"% ,4    " #U39Y:1L=-2)4   #-    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( /5-GEK0O#LV[@   "L"   1
M              "  <,   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M /5-GEJ97)PC$ 8  )PG   3              "  > !  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ ]4V>6OBWK41>!   '!$  !@
M     ("!(0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M /5-GEJ?H!OPL0(  .(,   -              "  ;4,  !X;"]S='EL97,N
M>&UL4$L! A0#%     @ ]4V>6I>*NQS     $P(   L              ( !
MD0\  %]R96QS+RYR96QS4$L! A0#%     @ ]4V>6JK$(A8S 0  (@(   \
M             ( !>A   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( /5-
MGEHD'INBK0   /@!   :              "  =H1  !X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( /5-GEIED'F2&0$  ,\#   3
M          "  ;\2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D
*/@(   D4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="avns-20250428.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avanos.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="avns-20250428.htm">avns-20250428.htm</File>
    <File>avns-20250428.xsd</File>
    <File>avns-20250428_lab.xml</File>
    <File>avns-20250428_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>avns-20250428_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "avns-20250428.htm": {
   "nsprefix": "avns",
   "nsuri": "http://www.avanos.com/20250428",
   "dts": {
    "inline": {
     "local": [
      "avns-20250428.htm"
     ]
    },
    "schema": {
     "local": [
      "avns-20250428.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "avns-20250428_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "avns-20250428_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 24
   },
   "report": {
    "R1": {
     "role": "http://www.avanos.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "avns-20250428.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "avns-20250428.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001606498-25-000085-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001606498-25-000085-xbrl.zip
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MMXZ^7G1\(H?BHP*BG<*P8>!EF<\&7OL@S*:'.O8ES;TGY!.W"E<*.U_:+1F
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M_O.>O-@6!=Q OW50MJ*O3DV#UJ<?'1WM%8-C15C&^S P1!U@_(JG+NGU5.)
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M]K L[N'"[*LG]9\Z@V2'] \O,E7HWR_^ZAWNA;7E^.EA#<%Q"TN6A/#10;Q
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M76FJW %\;^X - T_K(1SQ*3G^MW2_P=02P,$%     @ ]4V>6F3>5]I/"@
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M@-!$0!J&$K 4/$PPQ5IQ-_FT XTCI15VH]1:X[LJJR-=?54V/ E>BO/@[R'
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MTG 1-GR^C 2W274*L,748QV9SS*9E=G\\C>[-"TR/IL20X@T+ (5L[3:2,.
M,\I AA@A(5"*<._G$=ONC[V&? 0,UH@."\CM9/18/@ZBZ+AX=&#GMG+L).&W
M;MQV-]ZJL9/*QIJQVVK@'':>+TH^^W=V4S^$9H)&),(:PE#*JK8D(*(X 2)4
M3&F4RD0PKVEL V;DF6R)'5APK\?VK8ERG,^\Z0^;TOHR]Y_56HD-G]@VW;[,
MW-9*K7-Z:[=V%^=I_D,7[\6B++@L>PRS#?OCC:P:)OC/&NB_AQE*K<%[C9Y-
M3Z,-F%8"S3'2;N ^+'XOLK+4\ZK;<#O/EEMH%U/)XI@*)2$4J0'"8PV<4 $T
M%E(@B7'$5-_;=2O"D>_4*\Q@$[3_#;H]*_M%,YBKFW@<:3I):"<5+RFU>QQ-
M4CL)-:6UV_!P'3<T920U&%>ZXC$"DL0*4HPXV%4^D2K6L1!X:,<-O63'[>(N
M']YQ0P,Z;D[L#]AQVT7\(!TW-$B*W5Y?O..&VB2YW]A=EM6!D=GY53Y?;PMB
MF+.0(0W&, 9$8P0,ZQ@,YX@@G6"F>C_/>N[\R"*LX8(:SWE[U%8>]JMM"#LW
MD3D0<Y)5%P,O-6TY&TU$732:VNFT\5A#5"(L-*]7JCA!4F"6@J0L!(*2!+@F
M&E*"4T7"F'"N^\JEZ?C(4JF[L166XYI]@WN/Y9,G(\?54S\R;FNGELC]EDY-
M1^.MG%K"WU@XM?W??^-1A,1%5L[TE"0J3H1!@!A-@(2*@T@$ Q/'1! :14G:
M>\GTW/F1)5%C!+D)(O0W\?=@C>Z^X^@Q&3W:Q0,HNFG$E9W75J/G- 9M,WIT
M-OH6H^<TVK87;=FXBV=]ZOGQH-^OO+0*0JD61&E0J4J!2*&K;7L$TC1*J4)$
M\/[[#UH1CBRCQ[/<2]# H@85;'\=M>=EOY@&LW53E#-1)TGM)..EJW:/HXEK
M)Z&FPG8;NLOLO76F*H<?9_QR2A,L!"<AA+$T0*RH(*TVR89*1)C&FB,3]977
MAN<CR^H1*ZC ^HMID_U^$7ES<A-/3SI.DFD-W4LJFYY&DT@K@:8TV@U\>W$7
M_/Z3LLXRLVKOK5:^VE@5L%B YA0!B:F"U"@*$JE84(I,3*5;/ZX#:9R>G 4/
M-M$]STYUY:MO7^X 6?#JS;DGP*,WMX?<@/Y<E^>1>W1["&[WZ?:]P5VV%P6O
MOD+GV\.UR&=3;@AA"4H@C:OOKD&,@1 L!(&Y#$V$N*&]"\4-S\=>9RVQ@B58
M?Q%NLM\O.F].C@NK?G2<)-4:NI>$-CV-)IE6 DV)M!OXSF1?]656/0.>E_4I
MGR2DC!**04O)[ 2&):2AYJ!3205G%&/F>(9^$V"<>>L)T_'D4VM.^DY2_DR]
MYJ:^)#UFI'8F R:B9PY'GG_:Z6Q/.QUV@T\^-4_N4*PI8I@#)QP#,2&#E"81
M$$58S%,JF.E]M+ ;YL@RVSKB<Y!C3H,..+W,T::CGVDZTFFF_X=S3&XGF YS
M=FG=(+FP;YT:PD(2A@(X$C&0E"?V*M0021ERD40(Z][?9M%T/%:7L,)R;PW6
MU/MW!%T)>38"=W+QZOXU Q_4]*L=C=[K:X;?UN+;^+]O\??A6A>7MI;\9Y'?
ME5=6;C=\_C 53&NC(@X)%7:*BE,#J0ACP)@:'H6IT:KW@Z@=...4@FOH8(D=
MK,!=2\+V3/6M# ?S]RH07:E[%(H[B0VH%]O]CEPV[B2W73WN-N^2://3.+-7
M[UZM7\F67R+[[M7_ %!+ P04    " #U39Y:#T=XB]P&  #T,@  %0   &%V
M;G,M,C R-3 T,CA?<')E+GAM;-6;VV[C1A*&[^<IM-K;;:N/[&YC[,#KS"R,
M.!ECQD&"O1'Z4"T1H4B#I$]OOT7:RHY/LXRIA3DWDD4V6=5_?617%>GW/]QL
MBMD5U$U>E0=SMD?G,RA#%?-R=3#_]?PC,?,?#M^]>_\W0G[_Y^?3V8]5N-Q
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M,SCL;DS%3"0)<!=X_(6X@!? "15PC-.B2DH!XP".Y(^B2DMX^4=Q'>R]Z1C
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ME;JH-4J@(Q<7/S)Q\2''Q<=@Q/J&:,NQXD* .F))!"'*4F#F%6T5%][VO\V
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MD.03AWCBP5L4#L(EKL5I[=6)*$IL.6! <$RCHRL$DR>K8>]=!]Y-J_G[G\2
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MXR1+JP*OX*XMB(F@E^521!I7:&*+/BR8$#Q'P1,3*2[A;V: YH,/&\0=?G[
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M('A.!+".3[ /]AT?8-E*%=6 VX;H%:OM@%ZF_=W==WS; .4OQY4O);9Y.,K
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M#/$5_NDCXWI?WTBWFL;OFU2?LKFYMVGX7RC >L<?!^,Q B:=G02G@][[P>D
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M;'%/1W&:B5470JLKH M&E**A)H9U%99R6"^R+,8*4K"?Y13M:!(VH&;*4A>
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MC-1)&)?.T8 +EU*CO,39&9F)VQ^@@0,C6:<71J45\S*J':3)QK&Z49'OLJ+
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MR DHK63A G>XQZ7.ISZR1U ^+^$;0LJN'%)JR<L=&!D#M#49"W@X$?^(,8R
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M@O]-BUG\]O\!4$L! A0#%     @ ]4V>6I@VJQEP$@  &GL  !$
M     ( !     &%V;G,M,C R-3 T,C@N:'1M4$L! A0#%     @ ]4V>6O6A
M/7)@ @  \P8  !$              ( !GQ(  &%V;G,M,C R-3 T,C@N>'-D
M4$L! A0#%     @ ]4V>6F7X"_-Z-@  -3L  !0              ( !+A4
M &%V;G,M,C R-3 T,CA?9S$N:G!G4$L! A0#%     @ ]4V>6F3>5]I/"@
M%%@  !4              ( !VDL  &%V;G,M,C R-3 T,CA?;&%B+GAM;%!+
M 0(4 Q0    ( /5-GEH/1WB+W 8  /0R   5              "  5Q6  !A
M=FYS+3(P,C4P-#(X7W!R92YX;6Q02P$"% ,4    " #U39Y:SW]7K&4]   I
MA0$ '0              @ %K70  879N<V9O<FTX:U\P-#(X,C R-7AE>#$P
M,2YH=&U02P$"% ,4    " #U39Y:C)VN4QH<  !HF0  '0
M@ $+FP  879N<V9O<FTX:U\P-#(X,C R-7AE>#$P,BYH=&U02P4&      <
,!P#< 0  8+<

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>avns-20250428_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="avns-20250428.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001606498</identifier>
        </entity>
        <period>
            <startDate>2025-04-28</startDate>
            <endDate>2025-04-28</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-22">0001606498</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-23">false</dei:AmendmentFlag>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-24">2025-04-28</dei:DocumentPeriodEndDate>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-04-28</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">AVANOS MEDICAL, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-36440</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">46-4987888</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">5405 Windward Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-8">Suite 100 South</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-9">Alpharetta,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-10">GA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-11">30004</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-12">844</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-13">428-2667</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-14">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-15">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-17">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-18">Common Stock - $0.01 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-19">AVNS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-20">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-21">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
